Geron Corporation (NASDAQ:GERN) was rising 12.24% to $4.86 on Thursday after the biotech company announced the pricing of its underwritten public offering of common stock. Geron Corporation (NASDAQ:GERN) stock opened at $4.38 in last session, and closed at $5.35, while the day range of stock is $4.29 – $5.54. The stock showed a negative weekly performance of -6.30%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down almost 38% in the past one-month time frame. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock opened at $1.02, in last session and closed at $1.18, by gaining 1.18%. The 52 week range of the stock is $0.28 – $1.85. Company’s market capitalization is $173.13 million.
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) lost nearly $19 million in the fourth quarter, the company said Thursday, while its full-year earnings for 2013 essentially were flat. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) stock advanced 21.1% and finished the last session at $162.00. The EPS of the stock remained 1.77. Company’s market capitalization is $31.76 billion.
CytRx Corporation (Nasdaq:CYTR), announced its intention, subject to market and other conditions, to commence an underwritten public offering of its common stock. CytRx intends to use the net proceeds of the offering to fund clinical trials of its drug candidate aldoxorubicin and for general corporate purposes, which may include working capital, capital expenditures, research and development and other commercial expenditures. CytRx Corporation (NASDAQ:CYTR) stock opened the session at $7.43, and closed the session at $7.98. The 52 week range of the stock remained $1.83 – $8.35 and the day range was $7.40 – $8.35.